Arcutis Biotherapeutics Inc
ARQT
Market Cap$1.64B
Close$
$-8.09
157.7% downside
Current Fair Value
157.7% downsideOvervalued by 157.7% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $1.64 Billion |
|---|---|
| Enterprise Value | $1.70 Billion |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-1.16 |
| Beta | 1.78 |
| Outstanding Shares | 126,037,000 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -13.35 |
|---|---|
| PEG | 45.76 |
| Price to Sales | 14.02 |
| Price to Book Ratio | 14.02 |
| Enterprise Value to Revenue | 7.97 |
| Enterprise Value to EBIT | -14.3 |
| Enterprise Value to Net Income | -14 |
| Total Debt to Enterprise | 0.07 |
| Debt to Equity | 0.78 |
Revenue Sources
No data
Insider Trades
ESG Score
No data